Search - tctmd.com

Displaying 181 - 200 of 262

Sort: Relevancy | Date

News Daily News

FDA: Class 1 Recall for Boston Scientific’s RotaWire Elite, WireClip Torquer Guidewires

Shelley Wood

November 29, 2015

News Industry News

New Publication Featuring GlycoMark® Test Highlights Association of Hyperglycemic Excursions With Cardiovascular Outcomes And Mortality

November 17, 2015

News Industry News

Spectranetics Announces FDA Clearance of Turbo-Power(TM) Laser Atherectomy Catheter, Only Indicated Atherectomy Device for Treatment of In-Stent Restenosis

November 12, 2015

News Conference News AHA 2015

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Shelley Wood

November 05, 2015

News Industry News

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

November 02, 2015

News Industry News

Avinger Successfully Completes VISION IDE Trial for Pantheris(TM)

November 02, 2015

News Conference News TCT 2015

VISION: OCT-Guided Atherectomy Safe, Effective for PAD Intervention

October 14, 2015

News Industry News

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

October 14, 2015

News Daily News

混合成像方法具有针对易损冠状动脉斑块的高鉴别力

L.A. McKeown

October 13, 2015

News Daily News

Hybrid Imaging Approach Offers High Discriminatory Ability for Vulnerable Coronary Plaques

L.A. McKeown

October 13, 2015

News Daily News

Abordaje Híbrido con Pruebas de Imágenes Ofrece Elevada Capacidad de Discriminación de las Placas Coronarias Vulnerables

L.A. McKeown

October 13, 2015

News Industry News

Lilly to Discontinue Development of Evacetrapib for High-Risk Atherosclerotic Cardiovascular Disease

October 12, 2015

News Industry News

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

September 28, 2015

News Industry News

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

September 11, 2015

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Daily News

新型反义抑制剂能够降低高甘油三酯水平

August 13, 2015

News Daily News

Un Nuevo Inhibidor Antisentido Reduce los Niveles Altos de Triglicéridos

August 13, 2015

News Daily News

Novel Antisense Inhibitor Cuts High Triglyceride Levels

August 13, 2015

News Daily News

透析是 CLI 血管内介入治疗后结局不良的关键预测因素

L.A. McKeown

August 05, 2015

News Daily News

La Diálisis es un Predictor Importante de Resultados Adversos Post-Intervención Endovascular por ICE

L.A. McKeown

August 05, 2015

Advertisement

FDA: Class 1 Recall for Boston Scientific’s RotaWire Elite, WireClip Torquer Guidewires

New Publication Featuring GlycoMark® Test Highlights Association of Hyperglycemic Excursions With Cardiovascular Outcomes And Mortality

Spectranetics Announces FDA Clearance of Turbo-Power(TM) Laser Atherectomy Catheter, Only Indicated Atherectomy Device for Treatment of In-Stent Restenosis

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

Avinger Successfully Completes VISION IDE Trial for Pantheris(TM)

VISION: OCT-Guided Atherectomy Safe, Effective for PAD Intervention

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

混合成像方法具有针对易损冠状动脉斑块的高鉴别力

Hybrid Imaging Approach Offers High Discriminatory Ability for Vulnerable Coronary Plaques

Abordaje Híbrido con Pruebas de Imágenes Ofrece Elevada Capacidad de Discriminación de las Placas Coronarias Vulnerables

Lilly to Discontinue Development of Evacetrapib for High-Risk Atherosclerotic Cardiovascular Disease

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

新型反义抑制剂能够降低高甘油三酯水平

Un Nuevo Inhibidor Antisentido Reduce los Niveles Altos de Triglicéridos

Novel Antisense Inhibitor Cuts High Triglyceride Levels

透析是 CLI 血管内介入治疗后结局不良的关键预测因素

La Diálisis es un Predictor Importante de Resultados Adversos Post-Intervención Endovascular por ICE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content